Results 121 to 130 of about 50,232 (267)

Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.

open access: yesInternational Journal of Cardiology, 2019
BACKGROUND International guidelines recommend that for NSTEMI, the timing of invasive strategy (IS) is a function of patient's baseline risk. The extent to which this is delivered across and within healthcare systems is unknown.
M. Rashid   +10 more
semanticscholar   +1 more source

Takotsubo cardiomyopathy during armed conflict: A case series

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1494-1498, April 2025.
Sharon Bruoha   +13 more
wiley   +1 more source

Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature

open access: yesClinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT Clopidogrel is an antiplatelet agent widely utilized in cardiology. It is a prodrug activated in the liver by the cytochrome P450 isoform CYP2C19. Variability in the CYPC2C19 gene influences the activation and efficacy of clopidogrel. This is covered in guidelines from the Clinical Pharmacogenetics Implementation Consortium, the Dutch ...
Cinzia Dello Russo   +5 more
wiley   +1 more source

Common and distinct changes of multi-marker panel in acute and chronic non-obstructive coronary syndromes

open access: yesRomanian Journal of Cardiology
Applying the multi-marker panel in patients with STEMI, NSTEMI and non-obstructive chronic coronary disease (no-CCD) aiming for the estimation of either common or non-common changes of admission levels of 37 markers.
Munteanu Mihaela
doaj   +1 more source

Optimal Timing of Invasive Coronary Angiography following NSTEMI

open access: yesJournal of interventional cardiology, 2020
Objective To obtain a real-world perspective of the optimal timing of angiography performed within 24 hours of admission with non-ST elevation myocardial infarction (NSTEMI).
T. Mahendiran   +13 more
semanticscholar   +1 more source

Prehospital Risk Stratification Using Unsupervised Machine Learning in STEMI

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 5, May 2026.
Machine learning identified three phenotypes with 30‐day mortality of 3.4%, 22.1%, and 75%. Phenotype‐2 reveals an "occult high‐risk" group: hemodynamically stable yet six‐fold higher mortality. ABSTRACT Background ST‐elevation myocardial infarction (STEMI) exhibits substantial clinical heterogeneity complicating prehospital risk stratification ...
Ana Ramos‐Rodríguez   +7 more
wiley   +1 more source

Quality indicators for acute myocardial infarction : a position paper of the Acute Cardiovascular Care Association [PDF]

open access: yes, 2016
Evaluation of quality of care is an integral part of modern healthcare, and has become an indispensable tool for health authorities, the public, the press and patients.
Bonnefoy, Eric   +20 more
core   +1 more source

T Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age‐Related Diseases

open access: yesImmunological Reviews, Volume 339, Issue 1, May 2026.
ABSTRACT Cardiovascular diseases (CVD) are shaped by a complex interplay with immune mechanisms. In particular, the distinct roles of antigen‐specific T cell mechanisms are emerging as critical determinants across a broad spectrum of conditions, ranging from atherosclerosis, myocardial infarction (MI), heart failure (HF), and myocarditis. Because these
Leon Richter   +3 more
wiley   +1 more source

Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

open access: yesScientific Reports
The ST-elevation Myocardial Infarction (STEMI) and Non-ST-elevation Myocardial Infarction (NSTEMI) might occur because of coronary artery stenosis. The gene biomarkers apply to the clinical diagnosis and therapeutic decisions in Myocardial Infarction ...
Mohammad Elahimanesh   +5 more
doaj   +1 more source

Computed tomography angiography in the diagnosis of non-ST-elevation myocardial infarction: redefining our first line of defense

open access: yesInternational Journal of Cardiology: Heart & Vasculature
Background: Approximately one-third of patients with suspected non-ST-elevation myocardial infarction (NSTEMI) have non-obstructive coronary artery disease. Low-risk patients might benefit from early non-invasive diagnostic testing that can appropriately
Yvonne J.M. van Cauteren   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy